Get the Stockscreener App
0.00
100.00%
-2.72
Cosciens Biopharma Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.
See More
Previous Close:
$2.72
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$9.79M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$4.6054
Cosciens Biopharma Inc Stock (CSCI) Company Profile
Compare CSCI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSCI
Cosciens Biopharma Inc
|
0.00 | 9.79M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cosciens Biopharma Inc Stock (CSCI) Latest News
(CSCI) Trading Advice (CSCI:CA) - news.stocktradersdaily.com
(CSCI) Technical Pivots with Risk Controls (CSCI:CA) - news.stocktradersdaily.com
MSN Money - MSN
(CSCI) Strategic Investment Guide (CSCI:CA) - news.stocktradersdaily.com
Long Term Trading Analysis for (CSCI) (CSCI:CA) - news.stocktradersdaily.com
Is COSCIENS Biopharma Inc. stock a safe haven assetQuarterly Portfolio Report & Daily Volume Surge Signals - Newser
Why analysts upgrade COSCIENS Biopharma Inc. stockEarnings Summary Report & Entry Point Confirmation Alerts - Newser
Cosciens Biopharma Brief: Announcing Exclusive Distribution Agreement With Wuzhou Drug International For Macrilen In Hainan-Guangdong-Hong Kong-Macao Greater Bay Area And Singapore - MarketScreener
COSCIENS Biopharma Secures Exclusive Distribution Deal for Macrilen® in Asia - TipRanks
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore - The Manila Times
COSCIENS (TSX: CSCI) gives Wuzhou Macrilen rights, ten-year term, €800,000 order - Stock Titan
How COSCIENS Biopharma Inc. stock performs in rate cut cycles2025 Top Gainers & Capital Efficient Trading Techniques - moha.gov.vn
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN
(CSCI) Strategic Equity Report (CSCI:CA) - news.stocktradersdaily.com
Tools to assess COSCIENS Biopharma Inc.’s risk profileAnalyst Downgrade & Long Hold Capital Preservation Tips - newser.com
Is COSCIENS Biopharma Inc. stock a safe investment in uncertain marketsWall Street Watch & Low Drawdown Investment Ideas - newser.com
Can COSCIENS Biopharma Inc. stock deliver surprise earnings beat2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com
Chart overlay techniques for tracking COSCIENS Biopharma Inc.Earnings Recap Summary & Smart Money Movement Alerts - newser.com
(CSCI) Dynamic Trading Report (CSCI:CA) - news.stocktradersdaily.com
COSCIENS Biopharma Appoints Peter H. Puccetti as Interim CEO - MarketScreener
COSCIENS Biopharma Names Puccetti Interim CEO After Biehn Resigns - 富途牛牛
How currency fluctuations impact COSCIENS Biopharma Inc. stockQuarterly Trade Summary & Low Drawdown Trading Strategies - newser.com
Will COSCIENS Biopharma Inc. stock see insider buyingExit Point & Weekly Watchlist for Hot Stocks - newser.com
COSCIENS Biopharma appoints interim CEO - MSN
COSCIENS Biopharma Appoints New Interim CEO Amid Strategic Shifts - The Globe and Mail
COSCIENS Biopharma Inc. Announces Leadership Change - Lelezard
Cosciens Biopharma announces leadership change - MarketScreener
Live market analysis of COSCIENS Biopharma Inc.Dividend Hike & Growth Oriented Trading Recommendations - newser.com
COSCIENS Biopharma (TSX: CSCI) appoints Peter Puccetti interim CEO, succeeding Anna Biehn - Stock Titan
Cosciens Biopharma Inc Stock (CSCI) Financials Data
There is no financial data for Cosciens Biopharma Inc (CSCI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.31%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):